Altis helps biopharma run faster & more successful clinical trials using AI models trained on the industry's richest multimodal database.
Altis Labs has raised $6.0M in total funding. The most recent round was Seed. The last funding was announced in June 2023.
Altis Labs's investors include Creative Destruction Lab, Benchstrength, Debiopharm Innovation Fund, Richard Gliklich, Douglas Foster.
Altis Labs is headquartered in Toronto, Canada.
Altis helps biopharma run faster & more successful clinical trials using AI models trained on the industry's richest multimodal database.
Altis Labs is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Altis Labs — Funding & Investors." VCBacked, June 21, 2023, https://www.vcbacked.co/company/altis-labs. Accessed August 14, 2026.
VCBacked. (2023). Altis Labs — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/altis-labs
{{cite web |title=Altis Labs — Funding & Investors |url=https://www.vcbacked.co/company/altis-labs |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated